INBX News and Press, Inhibrx Inc.

2024-06-11 17:23:41 ET More on Inhibrx Biosciences, Inc. Inhibrx: Continued Advancement Even After INBRX-101 Sale To Sanofi Financial information for Inhibrx Biosciences, Inc. Read the full article on Seeking Alpha For further details see: Inhibrx Bioscie...

2024-06-07 14:42:51 ET Summary Inhibrx Biosciences, Inc.'s INBRX-109 is a tetravalent drug being developed for the treatment of patients with Ewing Sarcoma and other solid tumor types. It is expected that the Ewing Sarcoma Therapeutics market size could be worth as much as $424.42...

Smart Share Global Limited (EM) is expected to report for Q1 2024 American Rebel Holdings Inc. (AREB) is expected to report for Q1 2024 First Republic Bank (San Francisco, California) (FRCB) is expected to report for Q1 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ...

Inhibrx Biosciences Inc. (INBX) is expected to report for Q1 2024

2024-05-31 21:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-29 20:54:18 ET Summary Ole Andreas Halvorsen's 13F stock portfolio value decreased from $27.3B to $26.9B in Q1 2024. The number of holdings in the portfolio increased from 79 to 83. The largest five individual stock positions are Visa, Workday, Amazon.com, Philip Morri...

Fuse Medical Inc (FZMD) is expected to report for Q1 2024 PhoneX Holdings Inc (PXHI) is expected to report for Q1 2024 Avalon GloboCare Corp. (ALBT) is expected to report for Q1 2024 Ricoh Company Ltd ADR (RICOY) is expected to report for Q4 2024 Amplitech Group Inc. (AMPG) is exp...

2024-05-24 16:14:56 ET More on Inhibrx As more rare disease therapies launch, their prices are rising Seeking Alpha’s Quant Rating on Inhibrx Historical earnings data for Inhibrx Financial information for Inhibrx Read the full article on Seek...

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi PR Newswire SAN DIEGO , May 24, 2024 /PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX) ("Inhibrx," or the "Company") announced that, at a special meeting (the "Special Meeting"), the Company'...

2024-05-24 15:00:53 ET More on the markets S&P 500: It Is All About Liquidity SPY: Time To Be Contrarian And Underweight SPY ETF: Momentum Is In The Cards Stocks have more room to run - Invesco's Kristina Hooper Big bear Mike Wilson changes tune a...